Trust in COVID vaccines is growing

Mega, Emiliano Rodríguez

doi:10.1038/d41586-021-00368-6

Cited by 10 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, COVID-19 vaccination hesitancy has been studied heavily before and since the early stage of vaccine availability, with high variation in the willingness to be vaccinated among different communities ( Sallam, 2021 ; Feleszko et al, 2021 ; Lin et al, 2020 ). Several large multinational studies on vaccine acceptance have been conducted in 19 countries (n = 13,426) ( Lazarus et al, 2021 ), 15 countries (n = 18,526) ( Ipsos, 2020 ), 15 countries (n = 13,500) ( Mega, 2021 ), 14 countries (n = 12,777) ( Ipsos, 2021 ), and seven countries (n = 7662) ( Neumann-Böhme et al, 2020 ). Interestingly, none of which covered Arabic-speaking nations.…”

Section: Introductionmentioning

confidence: 99%

“…Also, the authorization of the use of Sinopharm vaccine by some Arab countries, despite the lack of sufficient safety and effectiveness evidence ( Cyranoski, 2020 ), may have an impact on the public’s trust in the vaccine and the health policies in these countries. Furthermore, attitudes toward the vaccines are affected by complex and dynamic interplaying factors, and considerable changes over time have been observed in acceptance and hesitancy rates ( Lazarus et al, 2021 ; Ipsos, 2020 ; Mega, 2021 ; Ipsos, 2021 ; Wang et al, 2021 ; Imperial College London, 2021 ; Lewis, 2020 ). For all of these reasons, the earlier local studies cannot be generalized to the Arab world, and further larger studies will present a clearer picture of the region.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs

Qunaibi

Helmy

Basheti

et al. 2021

eLife

105

View full text Add to dashboard Cite

Background: Vaccine hesitancy can limit the benefits of available vaccines in halting the spread of COVID-19 pandemic. Previously published studies paid little attention to Arab countries, which has a population of over 440 million. In this study, we present the results of the first large-scale multinational study that measures vaccine hesitancy among Arab-speaking subjects.Methods: An online survey in Arabic was conducted from 14-Jan-2021 to 29-Jan-2021. It consisted of 17 questions capturing demographic data, acceptance of COVID-19 vaccine, attitudes towards the need for COVID-19 vaccination and associated health policies, and reasons for vaccination hesitancy. R software- v.4.0.2 was used for data analysis and visualization.Results: The survey recruited 36,220 eligible participants (61.1% males, 38.9% females, mean age 32.6±10.8 years) from all the 23 Arab countries and territories (83.4%) and 122 other countries (16.6%). Our analysis shows a significant rate of vaccine hesitancy among Arabs in and outside the Arab region (83% and 81%, respectively). The most cited reasons for hesitancy are concerns about side effects and distrust in healthcare policies, vaccine expedited production, published studies and vaccine producing companies. We also found that female participants, participants 30-59 year-old, those with no chronic diseases, those with lower-level of academic education, and those who do not know the type of vaccine authorized in their countries are more hesitant to receive COVID-19 vaccination. On the other hand, participants who regularly receive the influenza vaccine, health care workers, and those from countries with higher rates of COVID-19 infections showed more vaccination willingness. Interactive representation of our results is posted on our project website at https://mainapp.shinyapps.io/CVHAA.Conclusion: Our results show higher vaccine hesitancy and refusal among Arab subjects, related mainly to distrust and concerns about side effects. Health authorities and Arab scientific community have to transparently address these concerns to improve vaccine acceptance.Funding: This study received no funding.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs

Qunaibi

Helmy

Basheti

et al. 2021

eLife

105

View full text Add to dashboard Cite

show abstract

“…Therefore, Covid- 19 vaccination hesitancy has been studied heavily before and since the early stage of vaccine availability, with high variation in the willingness to be vaccinated among different communities [3][4][5] . Several large multinational studies on vaccine acceptance have been conducted in 19 countries (n=13,426) 6 , 15 countries (n=18,526) 7 , 15 countries (n= 13,500) 8 , 14 countries (n= 12,777) 9 , and 7 countries (n = 7,662) 1 . Interestingly, none of which covered Arabic speaking nations.…”

Section: Introductionmentioning

confidence: 99%

A High Rate of COVID-19 Vaccine Hesitancy Among Arabs: Results of a Large-scale Survey

Helmy²,

Basheti

et al. 2021

Preprint

View full text Add to dashboard Cite

In this study, we present the results of the first large-scale multinational study (36,220 participants) that measures vaccine hesitancy among Arab-speaking subjects. Our analysis shows a significant rate of vaccine hesitancy among Arabs in and outside the Arab region (83% and 81%, respectively). The most cited reasons for hesitancy are concerns about side effects and distrust in healthcare policies, vaccine expedited production, published studies and vaccine producing companies. We also found that female participants, participants 30-59 year-old, those with no chronic diseases, those with lower-level of academic education, and those who do not know the type of vaccine authorized in their countries are more hesitant to receive COVID-19 vaccination. On the other hand, participants who regularly receive the influenza vaccine, health care workers, and those from countries with higher rates of COVID-19 infections showed more vaccination willingness. Interactive representation of our results is posted on our project website at https://mainapp.shinyapps.io/CVHAA.

show abstract

“…Obviously, vaccine hesitancy can slow down the containment of COVID-19 pandemic. However, a recent report on a survey in 15 countries showed that an increasing portion of people are willing to be vaccinated with COVID-19 vaccine (Mega 2021). It is encouraging that the vaccine confidence is growing in some countries.…”

Section: Vaccine Mistrust and Hesitancymentioning

confidence: 99%